Evidence map›Paper›PMID 33064809›Full record

ArticleThe Journal of infectious diseases2021

Association Between Cytomegalovirus and Epstein-Barr Virus Viremia And Human Immunodeficiency Virus DNA Levels in the Reservoir of Kenyan Infants Receiving Antiretroviral Therapy.

Jennifer A Slyker, Brandon Guthrie, Mark Pankau, Kenneth Tapia, Dalton Wamalwa, Sarah Benki-Nugent, Evelyn Ngugi, Meei-Li Huang, Irene Njuguna, Agnes Langat and 2 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Jennifer A SlykerDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Brandon GuthrieDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Mark PankauDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Kenneth TapiaDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Dalton WamalwaDepartment of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Sarah Benki-NugentDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Evelyn NgugiCenters for Disease Control and Prevention, CDC-Kenya, Nairobi, Kenya.
Meei-Li HuangDepartment of Laboratory Medicine, University of Washington, Seattle, Washington, USA.
Irene NjugunaDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Agnes LangatCenters for Disease Control and Prevention, CDC-Kenya, Nairobi, Kenya.
Grace John-StewartDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Dara LehmanDepartment of Global Health, University of Washington, Seattle, Washington, USA.
University of Washington · USCenters for Disease Control and Prevention · KEFred Hutch Cancer Center · USUniversity of Nairobi · KE

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSIONR01AI076105 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OVERBAUGH, JULIE M. · 2008 to 2023
$8.8M
Infant immune mechanisms of HIV reservoir size and decayR01HD094718 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C., LEHMAN, DARA ANN · 2017 to 2021
$3.6M
Pediatric HIV-1 in Africa: Pathogenesis and ManagementK24HD054314 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2006 to 2016
$1.2M
Vertical CMV transmission in the setting of maternal HIV-1 infection in KenyaK01AI087369 · NIAID · UNIVERSITY OF WASHINGTON · PI SLYKER, JENNIFER ANN · 2010 to 2014
$616k
NIAID NIH HHS K01 AI087369NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI076105NICHD NIH HHS K24 HD054314NICHD NIH HHS R01 HD094718
6 · The paper itself

Abstract

Identifying determinants of human immunodeficiency virus (HIV) reservoir levels may inform novel viral eradication strategies. Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) coinfections were assessed as predictors of HIV proviral DNA level in 26 HIV RNA-suppressed Kenyan children starting antiretroviral therapy before 7 months of age. Earlier acquisition of CMV and EBV and higher cumulative burden of systemic EBV DNA viremia were each associated with higher HIV DNA level in the reservoir after 24 months of antiretroviral therapy, independent of HIV RNA levels over time. These data suggest that delaying or containing CMV and EBV viremia may be novel strategies to limit HIV reservoir formation.

Indexed as

Cytomegalovirus InfectionsEpstein-Barr Virus InfectionsHIV InfectionsViral LoadViremiaAnti-Retroviral AgentsCytomegalovirusDNA, ViralHerpesvirus 4, HumanHIV-1HumansInfantKenyaAnti-Retroviral AgentsDNA, ViralCytomegalovirusEpstein-Barr virusHIVHIV reservoirpediatric

Identifiers

PMID33064809
PMCPMC8176631
OpenAlexW3092820300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.